Time matters: The importance of identifying progression early when treating with PADCEV in LA/mUC

CNSA proudly presented the following webinar in collaboration with Astellas. Our expert speakers walk through the data from the pivotal EV-301 trial, sharing strategies on how to effectively communicate these findings with patients.